Latest Insider Transactions at Arcellx, Inc. (ACLX)
This section provides a real-time view of insider transactions for Arcellx, Inc. (ACLX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Arcellx, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Arcellx, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 04
2025
|
Kavita Patel |
SELL
Open market or private sale
|
Direct |
1,500
-100.0%
|
$96,000
$64.57 P/Share
|
|
Feb 04
2025
|
Kavita Patel |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+50.0%
|
$9,000
$6.66 P/Share
|
|
Jan 14
2025
|
Kavita Patel |
SELL
Open market or private sale
|
Direct |
1,500
-70.16%
|
$99,000
$66.3 P/Share
|
|
Jan 14
2025
|
Kavita Patel |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+50.0%
|
$9,000
$6.66 P/Share
|
|
Jan 08
2025
|
Michelle Gilson CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,997
-29.44%
|
$291,781
$73.69 P/Share
|
|
Jan 08
2025
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,553
-12.41%
|
$259,369
$73.69 P/Share
|
|
Jan 08
2025
|
Rami Elghandour |
SELL
Open market or private sale
|
Direct |
13,837
-10.55%
|
$1,010,101
$73.69 P/Share
|
|
Jan 07
2025
|
Michelle Gilson CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
14,012
-12.94%
|
$1,050,900
$75.78 P/Share
|
|
Jan 07
2025
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,230
-12.87%
|
$317,250
$75.53 P/Share
|
|
Jan 07
2025
|
Rami Elghandour |
SELL
Open market or private sale
|
Direct |
16,474
-11.16%
|
$1,235,550
$75.53 P/Share
|
|
Jan 06
2025
|
Rami Elghandour |
SELL
Open market or private sale
|
Direct |
13,776
-8.45%
|
$1,060,752
$77.17 P/Share
|
|
Jan 06
2025
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
6,122
-8.62%
|
$471,394
$77.17 P/Share
|
|
Jan 06
2025
|
Michelle Gilson CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,102
-15.31%
|
$392,854
$77.17 P/Share
|
|
Jan 03
2025
|
Michelle Gilson CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
30,678
+28.31%
|
-
|
|
Jan 03
2025
|
Christopher Heery CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
49,557
+29.85%
|
-
|
|
Jan 03
2025
|
Rami Elghandour |
BUY
Exercise of conversion of derivative security
|
Direct |
106,194
+23.0%
|
-
|
|
Jan 03
2025
|
Rami Elghandour |
SELL
Open market or private sale
|
Direct |
14,857
-8.36%
|
$1,173,703
$79.55 P/Share
|
|
Jan 03
2025
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
6,602
-8.5%
|
$521,558
$79.55 P/Share
|
|
Jan 03
2025
|
Michelle Gilson CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,502
-14.17%
|
$434,658
$79.55 P/Share
|
|
Jan 02
2025
|
Rami Elghandour |
BUY
Exercise of conversion of derivative security
|
Direct |
55,459
+30.78%
|
-
|
|
Jan 02
2025
|
Christopher Heery CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
26,042
+36.87%
|
-
|
|
Jan 02
2025
|
Michelle Gilson CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
20,495
+46.59%
|
-
|
|
Dec 24
2024
|
Kavita Patel |
SELL
Open market or private sale
|
Direct |
1,500
-96.67%
|
$115,500
$77.26 P/Share
|
|
Dec 24
2024
|
Kavita Patel |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+50.0%
|
$9,000
$6.66 P/Share
|
|
Dec 03
2024
|
Kavita Patel |
SELL
Open market or private sale
|
Direct |
1,500
-45.67%
|
$138,000
$92.02 P/Share
|
|
Dec 03
2024
|
Kavita Patel |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+50.0%
|
$9,000
$6.66 P/Share
|
|
Nov 19
2024
|
Michelle Gilson CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+50.0%
|
$24,000
$8.66 P/Share
|
|
Nov 15
2024
|
Michelle Gilson CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,761
-70.42%
|
$158,490
$90.93 P/Share
|
|
Nov 12
2024
|
Kavita Patel |
SELL
Open market or private sale
|
Direct |
1,500
-100.0%
|
$159,000
$106.33 P/Share
|
|
Nov 12
2024
|
Kavita Patel |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+50.0%
|
$9,000
$6.66 P/Share
|
|
Nov 11
2024
|
Kavita Patel |
SELL
Open market or private sale
|
Direct |
15,238
-90.14%
|
$1,615,228
$106.3 P/Share
|
|
Nov 11
2024
|
Kavita Patel |
BUY
Exercise of conversion of derivative security
|
Direct |
15,238
+50.0%
|
$228,570
$15.0 P/Share
|
|
Nov 08
2024
|
Kavita Patel |
SELL
Open market or private sale
|
Direct |
33,763
-41.64%
|
$3,410,063
$101.88 P/Share
|
|
Nov 08
2024
|
Kavita Patel |
BUY
Exercise of conversion of derivative security
|
Direct |
33,763
+46.65%
|
$337,630
$10.83 P/Share
|
|
Nov 08
2024
|
Michelle Gilson CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
12,354
-47.32%
|
$1,247,754
$101.29 P/Share
|
|
Nov 08
2024
|
Michelle Gilson CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,200
+33.78%
|
$57,600
$8.66 P/Share
|
|
Nov 07
2024
|
Kavita Patel |
SELL
Open market or private sale
|
Direct |
8,478
-100.0%
|
$839,322
$99.3 P/Share
|
|
Nov 07
2024
|
Kavita Patel |
BUY
Exercise of conversion of derivative security
|
Direct |
8,478
+50.0%
|
$50,868
$6.66 P/Share
|
|
Oct 22
2024
|
Kavita Patel |
SELL
Open market or private sale
|
Direct |
1,500
-100.0%
|
$133,500
$89.69 P/Share
|
|
Oct 22
2024
|
Kavita Patel |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+50.0%
|
$9,000
$6.66 P/Share
|
|
Oct 01
2024
|
Kavita Patel |
SELL
Open market or private sale
|
Direct |
1,500
-100.0%
|
$123,000
$82.24 P/Share
|
|
Oct 01
2024
|
Kavita Patel |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+50.0%
|
$9,000
$6.66 P/Share
|
|
Sep 17
2024
|
Michelle Gilson CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
15,000
-42.21%
|
$1,155,000
$77.7 P/Share
|
|
Sep 17
2024
|
Michelle Gilson CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+40.63%
|
$120,000
$8.66 P/Share
|
|
Sep 10
2024
|
Kavita Patel |
SELL
Open market or private sale
|
Direct |
1,500
-100.0%
|
$111,000
$74.41 P/Share
|
|
Sep 10
2024
|
Kavita Patel |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+50.0%
|
$9,000
$6.66 P/Share
|
|
Sep 05
2024
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,421
-26.94%
|
$239,470
$70.02 P/Share
|
|
Sep 05
2024
|
Christopher Heery CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,421
+21.22%
|
$51,315
$15.0 P/Share
|
|
Sep 03
2024
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
27,451
-23.18%
|
$1,866,668
$68.09 P/Share
|
|
Sep 03
2024
|
Christopher Heery CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
27,451
+27.11%
|
$274,510
$10.64 P/Share
|